By Ijeoma UKAZU
Sygen Pharmaceutical Limited, Sygen Pharma, has pledged to promote communal well-being through innovation in the pharmaceutical industry while launching its corporate brand.
Established in March 2019, Sygen Pharma has further unveiled its plans to drive innovation in the pharmaceutical industry with a mission to develop and create access to high-quality medicines that yield successful outcomes.
Led by a management team with extensive multinational and international work experience, Sygen Pharma has also said that improving patients’ quality of life in the communities it operates is part of its mission.
The innovative pharmaceutical company subsequently acquired the assets of Nigerian German Chemicals, NGC, Plc to expand its pharmaceutical product portfolio.
Sygen Pharmaceutical’s product portfolio currently includes drugs in the following categories: antidiabetics, antipyretics, multivitamins, analgesics, antirheumatic, antifungal, antispasmodic, and so on.
Speaking at the formal brand launch, Charles Ogunwuyi, Chief Executive Officer, Sygen, said, “Sygen Pharmaceutical was established to grant access to high-quality medicines that yield successful outcomes and improve the quality of life of patients in our community; through our innovative approach to enhancing healthcare outcomes.
“At Sygen, we look beyond the functionality of providing medicines and seek to drive the total well-being of communities in a way that is vital to society,” Ogunwuyi added.
He also said, “There is a need in the pharmaceutical industry to shift the focus from humans as patients to people living in thriving communities. Sygen Pharmaceutical puts this in practice with the goal of promoting communal well-being and thriving communities.”
Sygen Pharmaceutical is building a reputation with its product quality and supply continuity. The Company continues to build a wide-ranging portfolio of products across brands and plans to rapidly expand its product line, Ogunwuyi noted.
With its formal brand launch, Sygen Pharmaceutical will redirect the focus on medicine as a function of ill health to provide a better life for communities altogether.
Since its inception, Sygen Pharma has established itself as a reputable organization within the pharmaceutical and healthcare industry and has gained the trust and respect of key stakeholders.
In addition to the portfolio of branded products acquired from NGC, Sygen will continue to grow its product portfolio across various therapeutic areas.
The organisation is driven by the quest to make a difference in the lives of people and communities. As a result, Sygen Pharma strives for continuous improvement and innovation geared toward expanding access to good-quality medicines in communities.
Sygen Pharmaceutical Ltd (Sygen Pharma) is an innovative branded generics life sciences organisation established in March 2019.
